Drug Shortage Report for RIVASTIGMINE

Last updated on 2017-03-24 History
Report ID 2307
Drug Identification Number 02417014
Brand name RIVASTIGMINE
Common or Proper name RIVASTIGMINE
Company Name PRO DOC LIMITEE
Market Status MARKETED
Active Ingredient(s) RIVASTIGMINE
Strength(s) 4.5MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100
ATC code N06DA
ATC description ANTI-DEMENTIA DRUGS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-03-14
Estimated end date
Actual end date 2017-03-16
Shortage status Resolved
Updated date 2017-03-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2925 BOULEVARD INDUSTRIEL
LAVAL, QUEBEC
CANADA H7L 3W9
Company contact information 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-03-14 English Compare
v2 2017-03-14 French Compare
v3 2017-03-14 English Compare
v4 2017-03-14 French Compare
v5 2017-03-15 English Compare
v6 2017-03-24 English Compare
v7 2017-03-24 French Compare

Showing 1 to 7 of 7